-
1
-
-
40549111528
-
Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe
-
A. Lackenby, O. Hungers, S.G. Dudman, A. Meijer, W.J. Paget, and A.J. Hay Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe Euro Surveill 13 2008 1 2
-
(2008)
Euro Surveill
, vol.13
, pp. 1-2
-
-
Lackenby, A.1
Hungers, O.2
Dudman, S.G.3
Meijer, A.4
Paget, W.J.5
Hay, A.J.6
-
3
-
-
48249093320
-
-
World Health Organization Geneva, Switzerland: WHO. [accessed 03.07.12]
-
World Health Organization. Influenza A(H1N1) virus resistance to oseltamivir. Geneva, Switzerland: WHO. http://www.who.int/influenza/patient- care/antivirals/oseltamivir-summary/en/. [accessed 03.07.12].
-
Influenza A(H1N1) Virus Resistance to Oseltamivir
-
-
-
4
-
-
84875004426
-
-
US Centers for Disease Control and Prevention Atlanta, GA: CDC. [accessed 03.07.12]
-
US Centers for Disease Control and Prevention. 2008-2009 Influenza season week 17 ending May 2, 2009. Atlanta, GA: CDC. http://www.cdc.gov/h1n1flu/pubs/ pdf/FluView-Week17.pdf. [accessed 03.07.12].
-
(2009)
2008-2009 Influenza Season Week 17 Ending May 2
-
-
-
5
-
-
0032515638
-
Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus
-
E.C. Claas, A.D. Osterhaus, R. van Beek, J.C. De Jong, G.F. Rimmelzwaan, and D.A. Senne Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus Lancet 351 1998 472 477
-
(1998)
Lancet
, vol.351
, pp. 472-477
-
-
Claas, E.C.1
Osterhaus, A.D.2
Van Beek, R.3
De Jong, J.C.4
Rimmelzwaan, G.F.5
Senne, D.A.6
-
6
-
-
77954433881
-
Zoonotic transmission of avian influenza virus (H5N1). Egypt, 2006-2009
-
A. Kandeel, S. Manoncourt, E. Abd el Kareem, A.N. Mohamed Ahmed, S. EI-Refaie, and H. Essmat Zoonotic transmission of avian influenza virus (H5N1). Egypt, 2006-2009 Emerg Infect Dis 16 2010 1101 1107
-
(2010)
Emerg Infect Dis
, vol.16
, pp. 1101-1107
-
-
Kandeel, A.1
Manoncourt, S.2
Abd El Kareem, E.3
Mohamed Ahmed, A.N.4
Ei-Refaie, S.5
Essmat, H.6
-
7
-
-
71149117904
-
-
World Health Organization Geneva, Switzerland: WHO. [accessed 02.07.12]
-
World Health Organization. Pandemic (H1N1) 2009 - update 105. Geneva, Switzerland: WHO. http://www.who.int/csr/don/2010-06-18/en/index.html. [accessed 02.07.12].
-
Pandemic (H1N1) 2009 - Update 105
-
-
-
9
-
-
84875004824
-
-
[accessed 03.07.12]
-
Kenko-Nippon 21 forum: survey on influenza. http://www.kenko- nippon21forum.gr.jp/free/prerelease/contents031.pdf. [accessed 03.07.12].
-
Kenko-Nippon 21 Forum: Survey on Influenza
-
-
-
10
-
-
4444369826
-
Resistant influenza A viruses in children treated with oseltamivir: Descriptive study
-
M. Kiso, K. Mitamura, Y. Sakai-Tagawa, K. Shiraishi, C. Kawakami, and K. Kimura Resistant influenza A viruses in children treated with oseltamivir: descriptive study Lancet 364 2004 759 765
-
(2004)
Lancet
, vol.364
, pp. 759-765
-
-
Kiso, M.1
Mitamura, K.2
Sakai-Tagawa, Y.3
Shiraishi, K.4
Kawakami, C.5
Kimura, K.6
-
11
-
-
34047226373
-
Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors
-
S. Hatakeyama, N. Sugaya, M. Ito, M. Yamazaki, M. Ichikawa, and K. Kimura Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors JAMA 297 2007 1435 1442
-
(2007)
JAMA
, vol.297
, pp. 1435-1442
-
-
Hatakeyama, S.1
Sugaya, N.2
Ito, M.3
Yamazaki, M.4
Ichikawa, M.5
Kimura, K.6
-
12
-
-
59749091876
-
CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity
-
M. Yamashita, T. Tomozawa, M. Kakuta, A. Tokumitsu, H. Nasu, and S. Kubo CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity Antimicrob Agents Chemother 53 2009 186 192
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 186-192
-
-
Yamashita, M.1
Tomozawa, T.2
Kakuta, M.3
Tokumitsu, A.4
Nasu, H.5
Kubo, S.6
-
13
-
-
77149156604
-
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration
-
S. Kubo, T. Tomozawa, M. Kakuta, M. Kakuta, A. Tokumitsu, and M. Yanashita Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration Antimicrob Agents Chemother 54 2010 1256 1264
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 1256-1264
-
-
Kubo, S.1
Tomozawa, T.2
Kakuta, M.3
Kakuta, M.4
Tokumitsu, A.5
Yanashita, M.6
-
14
-
-
69149093400
-
In vitro and in vivo characterization of new swine-origin H1N1 influenza virus
-
Y. Itoh, K. Shinya, M. Kiso, T. Watanabe, Y. Sakoda, and M. Hatta In vitro and in vivo characterization of new swine-origin H1N1 influenza virus Nature 460 2009 1021 1025
-
(2009)
Nature
, vol.460
, pp. 1021-1025
-
-
Itoh, Y.1
Shinya, K.2
Kiso, M.3
Watanabe, T.4
Sakoda, Y.5
Hatta, M.6
-
15
-
-
77649254587
-
Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses
-
M. Kiso, S. Kubo, M. Ozark, Q. Male Le, C.A. Nimrod, and M. Yamashita Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses PLoS Pathog 6 2010 e1000786
-
(2010)
PLoS Pathog
, vol.6
, pp. 1000786
-
-
Kiso, M.1
Kubo, S.2
Ozark, M.3
Male Le, Q.4
Nimrod, C.A.5
Yamashita, M.6
-
16
-
-
77952611625
-
Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection
-
N. Sugaya, and Y. Hashish Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection Antimicrob Agents Chemother 54 2010 2575 2582
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 2575-2582
-
-
Sugaya, N.1
Hashish, Y.2
-
17
-
-
78349241129
-
Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial
-
MARVEL Study Group
-
A. Watanabe, S.C. Chang, M.J. Kim, D.W. Chu, Y. Ohashi MARVEL Study Group Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: a double-blind, randomized, noninferiority clinical trial Clin Infect Dis 51 2010 1167 1175
-
(2010)
Clin Infect Dis
, vol.51
, pp. 1167-1175
-
-
Watanabe, A.1
Chang, S.C.2
Kim, M.J.3
Chu, D.W.4
Ohashi, Y.5
-
18
-
-
67349160808
-
Epidemiological survey of influenza-associated complications I. Clinical assessment of symptoms and signs, and medication
-
[in Japanese]
-
S. Yokota, T. Fujita, M. Mori, A. Nezu, A. Okumura, and M. Hosoya Epidemiological survey of influenza-associated complications I. Clinical assessment of symptoms and signs, and medication Jap J Pediatric Infect 111 2007 1545 1558 [in Japanese]
-
(2007)
Jap J Pediatric Infect
, vol.111
, pp. 1545-1558
-
-
Yokota, S.1
Fujita, T.2
Mori, M.3
Nezu, A.4
Okumura, A.5
Hosoya, M.6
-
19
-
-
70350328007
-
CS-8958, a prodrug of the novel neuraminidase inhibitor R-125489, demonstrates a favorable long-retention profile in the mouse respiratory tract
-
K. Koyama, M. Takahashi, M. Oitate, N. Nakai, H. Takakusa, and S. Miura CS-8958, a prodrug of the novel neuraminidase inhibitor R-125489, demonstrates a favorable long-retention profile in the mouse respiratory tract Antimicrob Agents Chemother 53 2009 4845 4851
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 4845-4851
-
-
Koyama, K.1
Takahashi, M.2
Oitate, M.3
Nakai, N.4
Takakusa, H.5
Miura, S.6
-
20
-
-
80053637254
-
Unique characteristics of long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) that explains its long-lasting activity
-
M. Yamashita, T. Hirai, K. Kubota, and S. Kubo Unique characteristics of long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) that explains its long-lasting activity Influenza Other Respir Viruses 5 Suppl. 1 2011 93 95
-
(2011)
Influenza Other Respir Viruses
, vol.5
, Issue.SUPPL. 1
, pp. 93-95
-
-
Yamashita, M.1
Hirai, T.2
Kubota, K.3
Kubo, S.4
-
21
-
-
78751692669
-
Laninamivir and its prodrug, CS-8958: Long-acting neuraminidase inhibitor for the treatment of influenza
-
M. Yamashita Laninamivir and its prodrug, CS-8958: long-acting neuraminidase inhibitor for the treatment of influenza Antivir Chem Chemother 21 2010 74 84
-
(2010)
Antivir Chem Chemother
, vol.21
, pp. 74-84
-
-
Yamashita, M.1
-
24
-
-
56749106483
-
Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: A comprehensive review
-
S. Toovey, C. Rayner, E. Prinssen, T. Chi, B. Donner, and B. Thakrar Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review Drug Saf 31 2008 1097 1114
-
(2008)
Drug Saf
, vol.31
, pp. 1097-1114
-
-
Toovey, S.1
Rayner, C.2
Prinssen, E.3
Chi, T.4
Donner, B.5
Thakrar, B.6
-
25
-
-
58849093994
-
The smaller number of influenza patients with neuropsychiatric events had taken oseltamivir beforehand
-
[in Japanese]
-
N. Tomono, and H. Shiro The smaller number of influenza patients with neuropsychiatric events had taken oseltamivir beforehand Kansenshogaku Zasshi 82 2008 613 618 [in Japanese]
-
(2008)
Kansenshogaku Zasshi
, vol.82
, pp. 613-618
-
-
Tomono, N.1
Shiro, H.2
-
26
-
-
77951648151
-
Prospective studies on neurological symptoms associated with influenza virus infection during the 2006-2007 influenza season (part 2) - Abnormal behaviors
-
M. Tominaga, T. Tanabe, K. Hara, C. Kinoshita, T. Kasahara, and M. Kou Prospective studies on neurological symptoms associated with influenza virus infection during the 2006-2007 influenza season (part 2) - abnormal behaviors J Pediatr Infect Dis Immunol 19 2007 468 472
-
(2007)
J Pediatr Infect Dis Immunol
, vol.19
, pp. 468-472
-
-
Tominaga, M.1
Tanabe, T.2
Hara, K.3
Kinoshita, C.4
Kasahara, T.5
Kou, M.6
-
27
-
-
70449636163
-
Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009
-
S. Jain, L. Kamimoto, A.M. Bramley, A.M. Schmitz, S.R. Benoit, and J. Louie Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009 N Engl J Med 361 2009 1935 1944
-
(2009)
N Engl J Med
, vol.361
, pp. 1935-1944
-
-
Jain, S.1
Kamimoto, L.2
Bramley, A.M.3
Schmitz, A.M.4
Benoit, S.R.5
Louie, J.6
-
28
-
-
77951625950
-
Epidemiological survey of influenza-associated complications II. A statistical analysis of symptoms and signs, and medication
-
T. Fujita, M. Mori, A. Nezu, A. Okumura, M. Hosoya, and H. Suzuki Epidemiological survey of influenza-associated complications II. A statistical analysis of symptoms and signs, and medication Jap J Pediatr Infect 111 2007 1559 1567
-
(2007)
Jap J Pediatr Infect
, vol.111
, pp. 1559-1567
-
-
Fujita, T.1
Mori, M.2
Nezu, A.3
Okumura, A.4
Hosoya, M.5
Suzuki, H.6
-
29
-
-
79955660384
-
A pharmacoepidemiological study on the relationship between neuropsychiatric symptoms and therapeutic drugs after influenza infection
-
T. Fujita, Y. Fujii, Y. Watanabe, H. Osaka, T. Wada, and M. Mori A pharmacoepidemiological study on the relationship between neuropsychiatric symptoms and therapeutic drugs after influenza infection Jpn J Pharmacoepidemiol 15 2010 73 95
-
(2010)
Jpn J Pharmacoepidemiol
, vol.15
, pp. 73-95
-
-
Fujita, T.1
Fujii, Y.2
Watanabe, Y.3
Osaka, H.4
Wada, T.5
Mori, M.6
|